Thank you to our speakers, sponsors, and delegates who joined us in
2024 for the summit! If you are interested in the 2025 event, please get in touch at
info@hansonwade.com
Bullet-Proof Data Quality, Enhance RWE Generation with AI & Natural Language Processing, Improve Collaboration with Stakeholders & Consolidate Integrated Evidence Planning to Transform Your RWE Strategy
Welcome to the IMPACCT Real World Evidence Summit
Digitalization and centralization of datasets have vastly increased the volume of RWD. Advances in AI, deep learning, and large language models have revolutionized big data analysis. Payers and regulators are prioritizing RWE in submissions. These three revolutions are driving a boom in RWE. However, questions remain for clinical, regulatory, and HEOR experts on how to best leverage and disseminate this data.
The IMPACCT Real World Evidence Summit is the premier industry event dedicated to uniting RWE and Evidence Generation experts. This is your opportunity to innovate and apply RWE across the drug development lifecycle, from external control arms to reimbursement.
In 2024 We Shined The Spotlight On:
- Consolidating data quality to increase the reliability of RWD
- Enabling effective cross-functional collaboration to streamline operational barriers
- Integrating AI and deep learning to enhance data analysis to seamlessly integrate RWD
- Developing a robust integrated evidence strategy to establish timelines across study designs.
Attendees of the 2024 summit had the opportunity to network with over 140 industry pioneers including Johnson & Johnson, Bayer, Pfizer, Takeda, Eli Lilly & Co, Sanofi, and more. Together, we forged a comprehensive evidence plan, broke free from silos, and bridged the gap between clinical research and practice.
The 2024 Expert Speaker Faculty Included:
Miriam Kore
Executive Director, Therapeutic Area Operations Leader Real World Evidence
Regeneron Pharmaceuticals Inc.
What Our Participants had to Say:
"I enjoyed the presentations from various stakeholders, small group discussions and networking sessions”- Pfizer
“It was valuable to connect with other RWE experts across the global landscape.”– J&J
“Relevant and state-of-the art presentations addressing challenges anyone working in the health data space and evidence generation will be facing. A great forum to discuss methodologies and innovations to bring us forward” - Eli Lilly & Co
“Very relevant topic and talks, networking opportunities” - Merck
“Very professional and knowledgeable speakers” – J&J
Our 2024 Partners:
